The FDA has approved the following name change to prevent medication errors (due to similar sounding names). You don't have to have
pharmacy technician training to see how easily this error could be made. Kapidex (dexlansoprazole) will now be called Dexilant. Dexilant will be marketed by Takeda Pharmaceuticals North America Inc. and the name change will go into effect in April 2010.
No comments:
Post a Comment